Health Care & Life Sciences » Pharmaceuticals | Innovus Pharmaceuticals Inc.

Innovus Pharmaceuticals Inc.

Innovus Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$3.95
Market Cap
$4.07 M
Shares Outstanding
2.62 M
Public Float
1.89 M

Profile

Address
8845 Rehco Road
San Diego California 92122
United States
Employees -
Website http://www.innovuspharma.com
Updated 07/08/2019
Innovus Pharmaceuticals, Inc. engages in the commercialization, licensing, and development of non-prescription medicine, and consumer care products for health and vitality, and respiratory diseases. It also provides packaged healthcare solutions through over-the-counter, medicines and consumer and health products, which it market directly or through commercial partners to primary care physicians, urologists, gynecologists and therapists, and directly to consumers through on-line channels, retailers and wholesalers. The company business model leverages the ability to acquire and in-license commercial products that are supported by scientific, and or clinical evidence, place them through it existing supply chain, retail and on-line channels.

Financials

View All
Created with Highcharts 5.0.14Innovus Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.3 9563 9564 8274 8274 2024 20213 70113 7016 5046 5048 2798 27920132014201520162017201802.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14Innovus Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.661 0301 0307357354 8184 8188 8168 81623 99023 99020132014201520162017201805k10k15k20k25k30k

Bassam B. Damaj
President, Chief Executive Officer & Director
Henry Jemil Esber
Chairman